Main Content
  • University of Maryland School of Medicine Announces Appointment of Chancellor Brit Kirwan, Other Prominent Leaders to its Board

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and UM SOM Board of Visitors Chairman, Michael E. Cryor today announced the appointment of new board members, including prominent leaders from academia, business and law.


  • First-Ever Possible Treatments for Middle East Respiratory Syndrome; UMSOM Researchers Identify Two Promising Candidates to Prevent and Treat Deadly Epidemic

    University of Maryland School of Medicine scientists and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating MERS, which can cause severe respiratory symptoms, and has a death rate of 40 percent.


  • University of Maryland School of Medicine Scientist Identifies “Decoy" Molecule That Could Help Sharply Reduce Risk of Flu Death

    The influenza virus can be lethal to those who are infected. But what is often just as dangerous is the body’s own reaction to the virus. This immune response consists of an inflammatory attack, meant to kill the virus. But if it gets too aggressive, this counterattack can end up harming the body’s own tissues, causing damage that can easily lead to death in vulnerable patients.


  • University of Maryland School of Medicine to Collaborate in New Center for Sports Medicine, Health and Human Performance

    University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today that the University of Maryland School of Medicine (UM SOM) will collaborate with the University of Maryland, College Park (UMCP) on a new center to study athletic performance and health. The Center for Sports Medicine, Health and Human Performance will employ innovative diagnostics and treatments for a broad spectrum of athletic injuries. Faculty physicians from the UM SOM will treat sports-related injuries in UMCP student-athletes, other students and the general public. These research efforts will focus on a range of areas, including concussion, traumatic brain injury, muscle-brain physiology and biochemistry, exoskeleton-robotic treatments and clinical and medical biomechanics.


  • Institute of Human Virology (IHV) Awarded $24.5M to Fight Botswana’s AIDS Epidemic

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine has received a five-year $24.5 million grant from the U.S. Centers for Disease Control and Prevention (CDC) through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to partner with the Government of Botswana and impact the HIV/AIDS epidemic in Botswana, and to demonstrate that comprehensive HIV/AIDS treatment programs can stop the epidemic. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush, and continued by President Barack Obama, to combat major infectious diseases around the world, including HIV.


  • University of Maryland Medicine Announces New National Program In Lung Healing to Develop Innovative Approaches for Preventing and Treating Acute Lung Disease

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new “Program in Lung Healing,” that will further the School’s position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.


News Archive » Submit News » RSS
Publication Archives »

State of the School School of Medicine Rankings Meet Our Students Make a Difference - Make a Gift